|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 1/16 | |
| A61P 11/00 | |||
| A61P 13/00 | |||
| A61P 13/08 | |||
| A61P 15/00 | |||
| A61K 39/00 | |||
| A61K 47/68 | |||
| C07K 16/00 | |||
| C07K 16/28 | |||
| C07K 16/22 | |||
| G01N 33/68 | |||
| A61P 1/18 |
| (11) | Number of the document | 2385955 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10729683.2 |
| Date of filing the European patent application | 2010-01-12 | |
| (97) | Date of publication of the European application | 2011-11-16 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/020820 |
| Date | 2010-01-12 |
| (87) | Number | WO 2010/081173 |
| Date | 2010-07-15 |
| (30) | Number | Date | Country code |
| 144105 P | 2009-01-12 | US | |
| 144110 P | 2009-01-12 | US | |
| 249416 P | 2009-10-07 | US | |
| 249441 P | 2009-10-07 | US |
| (72) |
STAGLIANO, Nancy, E., US
WEST, James, W., US
KAMATH, Kathryn, US
BESSETTE, Paul, H., US
GLUCK, Fred, US
SAGERT, Jason, US
DAUGHERTY, Patrick, US
|
| (73) |
CytomX Therapeutics, Inc.,
151 Oyster Point Blvd, Suite 400, South San Francisco, CA 94080,
US
|
| (54) | MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF |
| MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF |